Tango Therapeutics, Inc. (TNGX)
24.52
+0.64
(+2.68%)
USD |
NASDAQ |
Aug 24, 16:00
24.52
0.00 (0.00%)
After-Hours: 20:00
Tango Therapeutics Shareholders Equity (Quarterly) : 1.025B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.025B |
| March 31, 2026 | 391.51M |
| December 31, 2025 | 346.18M |
| September 30, 2025 | 160.03M |
| June 30, 2025 | 134.95M |
| March 31, 2025 | 166.76M |
| December 31, 2024 | 199.52M |
| September 30, 2024 | 229.17M |
| June 30, 2024 | 247.67M |
| March 31, 2024 | 264.45M |
| December 31, 2023 | 253.11M |
| September 30, 2023 | 276.60M |
| June 30, 2023 | 212.94M |
| Date | Value |
|---|---|
| March 31, 2023 | 227.26M |
| December 31, 2022 | 249.48M |
| September 30, 2022 | 273.07M |
| June 30, 2022 | 298.70M |
| March 31, 2022 | 320.36M |
| December 31, 2021 | 344.75M |
| September 30, 2021 | 365.41M |
| June 30, 2021 | 161.36M |
| March 31, 2021 | 162.12M |
| December 31, 2020 | 38.60M |
| September 30, 2020 | 162.43M |
| June 30, 2020 | 0.0245M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Revolution Medicines, Inc. | 2.606B |
| Erasca, Inc. | 361.87M |
| NovelStem International Corp. | -2.032M |
| Brainstorm Cell Therapeutics, Inc. | -11.60M |
| Summit Therapeutics, Inc. | 629.98M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.074B |
| Total Liabilities (Quarterly) | 49.35M |
| Debt to Equity Ratio | 0.0312 |
| Current Ratio | 50.82 |
| Net Debt Paydown Yield | 0.02% |